News & Events: Michael S. Conte, M.D.

Michael Conte, MD, Professor and Chief of the UCSF Division of Vascular & Endovascular Surgery, has recently been selected to serve as President of the Western Vascular Society for the 2020-2021 annual cycle. The Western Vascular Society has released the following statement regarding the appointment: Nominations Committee Names Dr. Michael Conte as President Elect of Western Vascular Society At the 34th Western Vascular Society Annual Business Meeting at the Fairmont Kei Lani, Maui, Past President, Dr. Steven Katz announced the nomination of Dr. Conte to be the society President [...]

The Global Vascular Guidelines for the Treatment of Chronic Limb-Threatening Ischemia (CLTI), an initiative to standardize and improve the quality of care of patients with CLTI worldwide, has been published in the Journal of Vascular Surgery (JVS), as a supplement to the June 2019 edition. The global effort was spearheaded by a trio of internationally renowned vascular surgeons who served as co-editors of the publication: Michael S. Conte, M.D., Professor and Chief of the Division of Vascular & Endovascular Surgery at UCSF,  Andrew W. Bradbury, MD of the University of Birmingham, [...]

Michael S. Conte, MD, chief of the Division of Vascular and Endovascular Surgery at UCSF, and one of nation's leading vascular surgeons, was awarded a 4-year, $1.7M U01 grant by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), a unit of the NIH, to fund one of 6 national centers in the Diabetic Foot Consortium.  Conte and podiatrist Alexander Reyzelman, DPM, a co-investigator on the grant, are co-Directors of the UCSF Center for Limb Preservation. The NIDDK research is being carried out via a network of Clinical Research Units (CRUs). The UCSF Diabetic Foot CRU is [...]

Michael S. Conte, M.D., Professor and Chief of the Division of Vascular & Endovascular Surgery  and Director of the Conte Lab, has been awarded two grants to develop a prototype medical device that will deliver bioactive lipid mediators to prevent "restenosis", the recurrent narrowing of blood vessels following interventions such as angioplasty, stenting, and bypass surgery. The bioactive compounds are being developed in the Conte Lab.  The first grant, a $200.000 Technology Development Award from the UC Center for Accelerated Innovation, is funded through a combination of grants and [...]

UCSF Magazine reports on the work of researchers using potent compounds, produced naturally from fish oil, to block the inflammation that can reblock arteries opened during stent procedures.  Michael S. Conte, M.D. Chief of the Division of Vascular & Endovascular Surgery and Director of the Conte Lab, and other researcher are collaborating in this endeavor:  Doctors implant more than a half million stents annually to prop open patients' blocked arteries and restore their blood flow. But often, inflammation triggers a process that reblocks the vessel as the area heals. UC San Francisco [...]

The NHLBI Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program has awarded Michael S. Conte, M.D., Professor & Chief of the Division of Vascular & Endovascular Surgery, a translational research grant to study the problem of vascular injury and develop prototype medical drugs and devices that effectively prevent restenosis, reduce vascular scarring, and improve vascular surgical outcomes. The grant is a collaboration between the Conte Lab and Tejal Desai, Ph.D., Director of the Therapeutic Microtechnology And Nanotechnology Laboratory and Chair of Bioengineering [...]

UCSF News reports that U.S. only a small number of nursing home residents are alive and ambulatory one year after undergoing lower extremity revascularization procedures with those still alive gaining little, if any, function: Only a few U.S. nursing home residents who undergo lower extremity revascularization procedures are alive and ambulatory a year after surgery, according to UCSF researchers, and most patients still alive gained little, if any, function. The study appears in the April 6 issue of JAMA Internal Medicine. "Our findings can inform conversations among physicians, [...]

Advances in the treatment of complex aortic aneurysms — especially novel endovascular devices and hybrid procedures — make it possible to choose the right procedure for the right patient at the right time to minimize risk and maximize long-term benefit, says Michael Conte, M.D., chief of the Division of Vascular and Endovascular Surgery at UCSF Medical Center. "We still perform a significant volume of open repair for complex aneurysms," Conte says. "But we're also one of only two or three centers in the country with deep experience in the use of branched stent grafts." A leading [...]

Despite substantial research showing that Peripheral artery disease (PAD) puts people at increased risk for heart attack, stroke, amputation and other vascular-related coniditions, PAD remains significantly underdiaganosed and undertreated. "These are very vulnerable patients," says Michael S. Conte, MD,, chief of Vascular and Endovascular Surgery at UCSF Medical Center and one of the country's leading PAD experts. "Most are over 70. Many are diabetics or smokers or both, and have other vascular conditions – and many are asymptomatic. Moreover, the course of the disease in [...]